Follow The Filings

ICCM IceCure Medical

IceCure Medical earnings company data as of 4:49 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 18 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ICCM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ICCM insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 5 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K CURRENT REPORT
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K CURRENT REPORT
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
SCHEDULE 13G —
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K CURRENT REPORT
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
424B5 PROSPECTUS SUPPLEMENT
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K REPORT OF FOREIGN PRIVATE ISSUER
6-K CURRENT REPORT
6-K REPORT OF FOREIGN PRIVATE ISSUER

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.